US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist

6.470
-0.530-7.57%

Trading Dec 12 12:48 ET

137.13MMarket Cap-1.18P/E (TTM)

Enanta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Sep 30, 2024

(Q4)Sep 30, 2024

(Q3)Jun 30, 2024

(Q2)Mar 31, 2024

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

23.64%-78.76M

51.86%-10.4M

54.01%-14.78M

-107.51%-28.6M

29.89%-24.99M

-21.67%-103.15M

-39.06%-21.6M

-8.53%-32.13M

47.74%-13.78M

-168.56%-35.64M

Net income from continuing operations

13.28%-116.05M

-2.55%-28.82M

42.00%-22.66M

17.26%-31.16M

-15.25%-33.41M

-9.91%-133.82M

-6.68%-28.11M

-23.23%-39.07M

-12.10%-37.66M

3.75%-28.99M

Operating gains losses

-89.33%16K

----

--150K

--143K

--0

----

Depreciation and amortization

-1.48%2.34M

-28.40%479K

-8.76%594K

15.00%621K

25.64%642K

-20.25%2.37M

2.14%669K

-9.08%651K

-34.31%540K

-34.49%511K

Other non cash items

140.85%2.14M

131.37%2.25M

-129.91%-588K

---304K

--786K

-464.37%-5.24M

-8,534.94%-7.17M

4,568.18%1.97M

----

Change In working capital

-11.14%7.13M

47.62%9.16M

318.93%2.7M

-119.67%-3.35M

90.10%-1.38M

18.19%8.02M

84.98%6.21M

80.67%-1.23M

13,186.92%17.01M

-240.64%-13.97M

-Change in receivables

-89.67%973K

-61.74%1.99M

-147.95%-844K

-97.46%120K

87.17%-289K

-20.15%9.42M

726.18%5.19M

336.88%1.76M

-47.19%4.72M

-150.81%-2.25M

-Change in prepaid assets

367.03%850K

-25.24%2.85M

-67.30%-4.33M

-33.19%2.31M

100.40%18K

-75.50%182K

299.90%3.81M

-201.93%-2.59M

234.60%3.46M

-267.82%-4.5M

-Change in payables and accrued expense

-63.39%-6.06M

62.61%-1.14M

536.10%2.53M

-181.80%-5.89M

78.56%-1.56M

39.31%-3.71M

-153.38%-3.04M

92.31%-579K

205.45%7.2M

-386.47%-7.29M

-Change in other current assets

51.53%6.81M

72.32%2.25M

9.95%1.43M

59.22%1.68M

73.86%1.45M

7.65%4.49M

53.23%1.3M

141.34%1.3M

-21.59%1.06M

-41.92%834K

-Change in other current liabilities

293.47%4.56M

429.88%3.92M

426.14%3.22M

-368.12%-1.54M

-36.99%-1.04M

38.11%-2.36M

-159.39%-1.19M

15.78%-987K

156.44%574K

34.91%-757K

-Change in other working capital

----

860.00%38K

----

---5K

Cash from discontinued investing activities

Operating cash flow

23.64%-78.76M

51.86%-10.4M

54.01%-14.78M

-107.51%-28.6M

29.89%-24.99M

-21.67%-103.15M

-39.06%-21.6M

-8.53%-32.13M

47.74%-13.78M

-168.56%-35.64M

Investing cash flow

Cash flow from continuing investing activities

208.69%58.24M

61.14%19.07M

95.65%-6.35M

25.36%58.62M

-139.07%-13.12M

-197.60%-53.58M

-58.07%11.84M

-998.57%-145.75M

233.40%46.77M

-26.22%33.57M

Net PPE purchase and sale

-98.15%-17.95M

-554.31%-8.95M

-204.14%-6.54M

30.00%-1.67M

75.06%-787K

-326.26%-9.06M

4.80%-1.37M

-756.97%-2.15M

-3,120.27%-2.38M

-769.42%-3.16M

Net investment purchase and sale

271.12%76.18M

112.24%28.02M

100.14%197K

22.67%60.29M

-133.57%-12.33M

-178.08%-44.52M

-55.49%13.2M

-971.82%-143.6M

240.50%49.15M

-19.93%36.73M

Cash from discontinued investing activities

Investing cash flow

208.69%58.24M

61.14%19.07M

95.65%-6.35M

25.36%58.62M

-139.07%-13.12M

-197.60%-53.58M

-58.07%11.84M

-998.57%-145.75M

233.40%46.77M

-26.22%33.57M

Financing cash flow

Cash flow from continuing financing activities

-113.94%-27.63M

-31,269.57%-7.22M

-103.33%-6.65M

-216.43%-6.41M

-2,541.86%-7.35M

889.00%198.13M

-100.78%-23K

4,751.33%199.88M

-160.49%-2.03M

-96.88%301K

Net issuance payments of debt

---27.48M

---7.26M

----

---7.17M

--0

----

--0

Proceeds from stock option exercised by employees

-93.34%147K

--68K

-86.00%28K

-94.22%51K

--0

-89.62%2.21M

--0

-95.15%200K

-76.80%882K

-89.18%1.13M

Net other financing activities

-100.15%-294K

17.39%-19K

-93.22%13.54M

-368.61%-13.63M

77.82%-183K

16,041.25%195.92M

-2,200.00%-23K

--199.68M

-545.01%-2.91M

-6.18%-825K

Cash from discontinued financing activities

Financing cash flow

-113.94%-27.63M

-31,269.57%-7.22M

-103.33%-6.65M

-216.43%-6.41M

-2,541.86%-7.35M

889.00%198.13M

-100.78%-23K

4,751.33%199.88M

-160.49%-2.03M

-96.88%301K

Net cash flow

Beginning cash position

86.31%89.36M

-59.91%39.74M

-12.49%67.51M

-4.96%43.9M

86.31%89.36M

-17.04%47.96M

206.62%99.15M

85.46%77.15M

-53.66%46.19M

-17.04%47.96M

Current changes in cash

-216.33%-48.16M

114.89%1.46M

-226.22%-27.77M

-23.73%23.61M

-2,466.63%-45.46M

520.16%41.39M

-162.64%-9.79M

337.52%22M

153.30%30.96M

-104.23%-1.77M

End cash Position

-53.89%41.2M

-59.91%39.74M

-12.49%67.51M

-4.96%43.9M

86.31%89.36M

206.62%99.15M

85.46%77.15M

-53.66%46.19M

Free cash flow

13.81%-96.71M

15.76%-19.35M

37.81%-21.32M

-87.24%-30.27M

33.56%-25.78M

-29.12%-112.21M

-35.35%-22.97M

-14.83%-34.28M

38.88%-16.17M

-184.56%-38.8M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Sep 30, 2024	(Q4)Sep 30, 2024	(Q3)Jun 30, 2024	(Q2)Mar 31, 2024	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	23.64%-78.76M	51.86%-10.4M	54.01%-14.78M	-107.51%-28.6M	29.89%-24.99M	-21.67%-103.15M	-39.06%-21.6M	-8.53%-32.13M	47.74%-13.78M	-168.56%-35.64M
Net income from continuing operations	13.28%-116.05M	-2.55%-28.82M	42.00%-22.66M	17.26%-31.16M	-15.25%-33.41M	-9.91%-133.82M	-6.68%-28.11M	-23.23%-39.07M	-12.10%-37.66M	3.75%-28.99M
Operating gains losses	-89.33%16K	----	----	----	----	--150K	--143K	--0	----	----
Depreciation and amortization	-1.48%2.34M	-28.40%479K	-8.76%594K	15.00%621K	25.64%642K	-20.25%2.37M	2.14%669K	-9.08%651K	-34.31%540K	-34.49%511K
Other non cash items	140.85%2.14M	131.37%2.25M	-129.91%-588K	---304K	--786K	-464.37%-5.24M	-8,534.94%-7.17M	4,568.18%1.97M	----	----
Change In working capital	-11.14%7.13M	47.62%9.16M	318.93%2.7M	-119.67%-3.35M	90.10%-1.38M	18.19%8.02M	84.98%6.21M	80.67%-1.23M	13,186.92%17.01M	-240.64%-13.97M
-Change in receivables	-89.67%973K	-61.74%1.99M	-147.95%-844K	-97.46%120K	87.17%-289K	-20.15%9.42M	726.18%5.19M	336.88%1.76M	-47.19%4.72M	-150.81%-2.25M
-Change in prepaid assets	367.03%850K	-25.24%2.85M	-67.30%-4.33M	-33.19%2.31M	100.40%18K	-75.50%182K	299.90%3.81M	-201.93%-2.59M	234.60%3.46M	-267.82%-4.5M
-Change in payables and accrued expense	-63.39%-6.06M	62.61%-1.14M	536.10%2.53M	-181.80%-5.89M	78.56%-1.56M	39.31%-3.71M	-153.38%-3.04M	92.31%-579K	205.45%7.2M	-386.47%-7.29M
-Change in other current assets	51.53%6.81M	72.32%2.25M	9.95%1.43M	59.22%1.68M	73.86%1.45M	7.65%4.49M	53.23%1.3M	141.34%1.3M	-21.59%1.06M	-41.92%834K
-Change in other current liabilities	293.47%4.56M	429.88%3.92M	426.14%3.22M	-368.12%-1.54M	-36.99%-1.04M	38.11%-2.36M	-159.39%-1.19M	15.78%-987K	156.44%574K	34.91%-757K
-Change in other working capital	----	----	----	----	860.00%38K	----	----	----	----	---5K
Cash from discontinued investing activities
Operating cash flow	23.64%-78.76M	51.86%-10.4M	54.01%-14.78M	-107.51%-28.6M	29.89%-24.99M	-21.67%-103.15M	-39.06%-21.6M	-8.53%-32.13M	47.74%-13.78M	-168.56%-35.64M
Investing cash flow
Cash flow from continuing investing activities	208.69%58.24M	61.14%19.07M	95.65%-6.35M	25.36%58.62M	-139.07%-13.12M	-197.60%-53.58M	-58.07%11.84M	-998.57%-145.75M	233.40%46.77M	-26.22%33.57M
Net PPE purchase and sale	-98.15%-17.95M	-554.31%-8.95M	-204.14%-6.54M	30.00%-1.67M	75.06%-787K	-326.26%-9.06M	4.80%-1.37M	-756.97%-2.15M	-3,120.27%-2.38M	-769.42%-3.16M
Net investment purchase and sale	271.12%76.18M	112.24%28.02M	100.14%197K	22.67%60.29M	-133.57%-12.33M	-178.08%-44.52M	-55.49%13.2M	-971.82%-143.6M	240.50%49.15M	-19.93%36.73M
Cash from discontinued investing activities
Investing cash flow	208.69%58.24M	61.14%19.07M	95.65%-6.35M	25.36%58.62M	-139.07%-13.12M	-197.60%-53.58M	-58.07%11.84M	-998.57%-145.75M	233.40%46.77M	-26.22%33.57M
Financing cash flow
Cash flow from continuing financing activities	-113.94%-27.63M	-31,269.57%-7.22M	-103.33%-6.65M	-216.43%-6.41M	-2,541.86%-7.35M	889.00%198.13M	-100.78%-23K	4,751.33%199.88M	-160.49%-2.03M	-96.88%301K
Net issuance payments of debt	---27.48M	---7.26M	----	----	---7.17M	--0	--0	----	----	--0
Proceeds from stock option exercised by employees	-93.34%147K	--68K	-86.00%28K	-94.22%51K	--0	-89.62%2.21M	--0	-95.15%200K	-76.80%882K	-89.18%1.13M
Net other financing activities	-100.15%-294K	17.39%-19K	-93.22%13.54M	-368.61%-13.63M	77.82%-183K	16,041.25%195.92M	-2,200.00%-23K	--199.68M	-545.01%-2.91M	-6.18%-825K
Cash from discontinued financing activities
Financing cash flow	-113.94%-27.63M	-31,269.57%-7.22M	-103.33%-6.65M	-216.43%-6.41M	-2,541.86%-7.35M	889.00%198.13M	-100.78%-23K	4,751.33%199.88M	-160.49%-2.03M	-96.88%301K
Net cash flow
Beginning cash position	86.31%89.36M	-59.91%39.74M	-12.49%67.51M	-4.96%43.9M	86.31%89.36M	-17.04%47.96M	206.62%99.15M	85.46%77.15M	-53.66%46.19M	-17.04%47.96M
Current changes in cash	-216.33%-48.16M	114.89%1.46M	-226.22%-27.77M	-23.73%23.61M	-2,466.63%-45.46M	520.16%41.39M	-162.64%-9.79M	337.52%22M	153.30%30.96M	-104.23%-1.77M
End cash Position	-53.89%41.2M	-53.89%41.2M	-59.91%39.74M	-12.49%67.51M	-4.96%43.9M	86.31%89.36M	86.31%89.36M	206.62%99.15M	85.46%77.15M	-53.66%46.19M
Free cash flow	13.81%-96.71M	15.76%-19.35M	37.81%-21.32M	-87.24%-30.27M	33.56%-25.78M	-29.12%-112.21M	-35.35%-22.97M	-14.83%-34.28M	38.88%-16.17M	-184.56%-38.8M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Heat List

Overall

No Data